| Financial Year |
March 31 2023 |
| Monetary Funds |
159,629,154.27 |
| Held-for-trading Financial Assets |
5,894,399.17 |
| Notes Receivable |
19,317,060.91 |
| Accounts Receivable |
563,186,180.89 |
| Advances to Suppliers |
35,954,546.56 |
| Other Receivables |
31,797,942.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
247,579,056.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,892,431.76 |
| Total Current Assets |
1,124,962,074.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
15,631,762.21 |
| Investment Properties |
35,425,112.28 |
| Fixed Assetes |
317,895,740.79 |
| Under-construction Projects |
82,016,334.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
159,512,262.03 |
| R&D expenses |
-- |
| Goodwill |
191,121,720.18 |
| Long-Term Deferred and Prepaid Expenses |
19,241,869.75 |
| Deferred Income Tax Assets |
60,964,919.07 |
| Other Non-Current Assets |
34,750,028.36 |
| Sub-Total of Non-Current Assets |
950,802,064.58 |
| Total Assets |
2,075,764,138.85 |
| Short-Term Loans |
241,231,947.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
299,653,051.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,682,853.11 |
| Taxes Payable |
16,015,941.61 |
| Interest Payable |
-- |
| Dividend Payable |
1,284,047.00 |
| Other payables |
317,938,623.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,021,141.06 |
| Other Current Liabilities |
797,001.77 |
| Sub-Total of Current Liabilities |
930,023,910.10 |
| Long-term Loans |
76,720,983.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,256,820.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
125,810,731.60 |
| Total Liabilities |
1,055,834,641.70 |
| Paid-In Capital(Or Share Stock) |
212,121,980.00 |
| Capital Surplus |
118,736,244.68 |
| Surplus Reserve |
18,718,008.84 |
| LESS:Treasury Stock |
55,763,606.29 |
| Undistributed Profits |
556,622,799.81 |
| Minority Stockholder's Interest |
169,001,200.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
850,928,296.53 |
| Owner's Equity（Stockholder's Equity） |
1,019,929,497.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,075,764,138.85 |
